Page last updated: 2024-08-17

tetrabenazine and Parkinson Disease

tetrabenazine has been researched along with Parkinson Disease in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (13.25)	18.7374
1990's	6 (7.23)	18.2507
2000's	18 (21.69)	29.6817
2010's	44 (53.01)	24.3611
2020's	4 (4.82)	2.80

Authors

Authors	Studies
Leitinger, G; Maurer, C; Radulović, S; Sunkara, S	1
Chen, YH; Hoffer, BJ; Huang, EY; Kuo, TT; Ma, KH; Olson, L; Tseng, KY; Wang, V	1
Fu, JF; Klyuzhin, IS; McKeown, MJ; Sossi, V; Stoessl, AJ	1
Bohnen, NI; D'Cruz, N; Kanel, P; Müller, MLTM; Sanchez-Catasus, CA; Yeh, FC	1
Chen, ZA; Hsiao, IT; Hsu, CH; Huang, SL; Kung, MP; Lin, KJ; Weng, CC; Wey, SP; Yen, TC	1
Bohnen, NI; Chou, KL; Gilman, S	1
Bohnen, JLB; Bohnen, NI; Haugen, J; Müller, MLTM	1
Gjedde, A; Jakobsen, S; Landau, AM; Phan, JA; Romero-Ramos, M; Stokholm, K; Vang, K; Zareba-Paslawska, J	1
Fasano, A; Levy, A	1
Barrett, MJ; Bassett, AS; Berman, BD; Booij, J; Boot, E; Borg, M; Bourdain, F; Butcher, NJ; Charles, P; Clerinx, K; Colin, O; Danaila, T; Drapier, S; Dufournet, B; Fiksinski, AM; Gasser, T; Jacquette, A; Kaneko, S; Lang, AE; Marras, C; Masellis, M; Mills, K; Mok, KY; Mutez, E; Nguyen, K; Perandones, C; Plate, A; Prontera, P; Swillen, A; Udow, S; Vergaelen, E; Vogels, A; Williams, NM; Wood, NW	1
Alstrup, AKO; Brooks, DJ; Doudet, DJ; Glud, AN; Hinz, R; Jakobsen, S; Kirik, D; Landau, AM; Landeck, N; Lillethorup, TP; Sørensen, JC; Vang, K	1
Hsiao, IT; Jung Lung, H; Lin, KJ; Wen, MC; Weng, YH	1
Cervantes-Arriaga, A; Díaz-Meneses, IE; Kerik, NE; Pérez-Lohman, C; Rodríguez-Violante, M	1
Albin, RL; Archer, DB; Bohnen, NI; Burciu, RG; Müller, MLTM; Ofori, E; Roy, A; Vaillancourt, DE; Yang, J	1
Bohnen, NI; Dayalu, P; Kwak, Y; Müller, ML; Seidler, RD	1
Bohnen, NI; Dayalu, P; Kwak, Y; Miller, NS; Müller, ML; Seidler, RD	1
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Scott, PJ; Studenski, S	1
Hsiao, IT; Hsieh, CJ; Kung, MP; Lin, KJ; Lin, SC; Lin, WY; Lu, CS; Weng, YH; Wey, SP; Yen, TC	1
Hsiao, IT; Hsieh, CJ; Kung, MP; Lin, KJ; Lin, WY; Lu, CS; Weng, YH; Wey, SP; Yen, TC	2
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML	1
Miklya, I	1
Albin, RL; Bohnen, NI; Constantine, GM; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Scott, PJ; Studenski, S	1
Blesa, J; Cavada, C; Hornykiewicz, O; Obeso, JA; Pifl, C; Rajput, A; Rajput, AH; Reither, H	1
Bohnen, NI; Chou, KL; Koeppe, RA; Lenhart, A	1
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M; Scott, PJ	1
Collantes, M; Delgado, M; Ecay, M; Gago, B; Iglesias, E; Juri, C; Marín, C; Molinet-Dronda, F; Obeso, JA; Peñuelas, I; Prieto, E; Quiroga-Varela, A	1
Contreras-Mora, HM; Correa, M; Milligan, MN; Podurgiel, SJ; Purcell, LJ; Salamone, JD; Yohn, SE	1
Hsiao, IT; Hsieh, CJ; Huang, CC; Huang, CY; Lin, KJ; Liu, CH; Tsao, E; Weng, YH; Yen, TC	1
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M; Scott, PJ; Shah, N	1
Albin, RL; Bohnen, NI; Davatzikos, C; Foerster, BR; Frey, KA; Herman, WH; Hsieh, M; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M	1
Jankovic, J; Vijayakumar, D	1
Chen, X; Gao, R; Smith, G; Wong, DF; Yang, A; Zhang, G; Zhou, Y	1
Chan, MH; Chao, KT; Chen, ZA; Ee, TW; Hsiao, IT; Hsu, CH; Kung, MP; Lin, KJ; Weng, CC; Wey, SP; Yen, TC	1
Frey, KA; Gilman, S; Junck, L; Koeppe, RA; Wernette, K	1
Boileau, I; Guttman, M; Houle, S; Kish, SJ; Rusjan, P; Saint-Cyr, JA; Selby, P; Tong, J; Wilkins, D; Wilson, AA	1
de la Fuente-Fernandez, R; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Troiano, AR	1
Vingerhoets, FJ	1
de la Fuente-Fernández, R; McCormick, S; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ	1
Ackermann, U; Dhamija, RK; Drago, J; Ellis, JR; Jones, G; Kung, HF; Mulligan, RS; O'Keefe, G; Okamura, N; Pejoska, S; Pontecorvo, MJ; Rowe, CC; Skovronsky, D; Villemagne, VL	1
Kung, HF; Lieberman, B; Liu, J; Liu, Y; Plössl, K; Zhu, L	1
Hou, C; Kung, HF; Lieberman, BP; Oya, S; Parhi, AK; Ploessl, K; Wang, JL	1
Chang, HP; Hsiao, IT; Kung, MP; Lin, KJ; Lu, CS; Skovronsky, D; Weng, YH; Wey, SP; Yen, TC	1
Chen, JJ	1
Au, WL; Calne, DB; Cragg, J; de la Fuente-Fernández, R; Kuramoto, L; Lee, CS; Mak, E; McCormick, S; McKenzie, J; Ramachandiran, N; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ	1
Albin, RL; Bogan, CW; Bohnen, NI; Frey, KA; Kilbourn, MR; Koeppe, RA; Müller, ML; Zarzhevsky, N	1
Franch, O; Kurtis, MM	1
Chang, CJ; Hsiao, IT; Hsieh, CJ; Kung, MP; Lin, KJ; Lin, WY; Lu, CS; Skovronsky, D; Weng, YH; Wey, SP; Yen, TC	1
Aasly, JO; Armaly, J; Furay, AR; Hasegawa, K; Leverenz, JB; Shi, M; Sossi, V; Stoessl, AJ; Uitti, RJ; Wang, Y; Wszolek, ZK; Yokoyama, T; Zabetian, CP; Zhang, J	1
Akdeniz, M; Yaman, A; Yaman, H	1
Albin, RL; Bohnen, NI; Frey, KA; Gilman, S; Kilbourn, MR; Koeppe, RA; Kotagal, V; Müller, ML	1
Chan, P; Choi, SR; Kung, HF; Lieberman, BP; Liu, Y; Pan, Z; Ploessl, K; Qiao, H; Wu, J; Zhu, L	1
Albin, RL; Bohnen, NI; Frey, KA; Koeppe, RA; Kotagal, V; Müller, ML; Petrou, M	1
Calne, DB; De La Fuente-Fernández, R; Furtado, S; Furukawa, Y; Guttman, M; Lee, CS; Ruth, TJ; Stoessl, AJ	1
Kumar, A; Lee, CS; Mann, S; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ	1
Brooks, DJ; Frey, KA; Marek, KL; Oakes, D; Paty, D; Prentice, R; Shults, CW; Stoessl, AJ	1
Leenders, KL; Linazasoro, G	1
Burman, J; Edwards, RH; Freimer, NB; Glatt, C; Tran, CH	1
Calne, DB; de la Fuente-Fernández, R; Kuramoto, L; Lee, CS; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ	1
Ahlskog, JE; Albin, RL; Brooks, DJ; Carbon, M; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Guttman, M; Gwinn-Hardy, K; Holloway, R; Innis, R; Katz, RG; Kieburtz, K; Kish, SJ; Lange, N; Langston, JW; Marek, K; McFarland, H; Morin, L; Moy, C; Murphy, D; Oertel, WH; Oliver, G; Palesch, Y; Powers, W; Ravina, B; Seibyl, J; Sethi, KD; Sheehy, P; Shults, CW; Stoessl, AJ	1
Adams, JR; Calne, DB; Farrer, M; Gasser, T; Lee, CS; Mak, E; Mckenzie, J; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Strongosky, A; Uitti, RJ; van Netten, H; Wszolek, ZK	1
Albin, RL; Bohnen, NI; Frey, KA; Kilbourn, MR; Koeppe, RA; Minoshima, S; Wernette, KA	1
Martin, WR; Schulzer, M; Stoessl, AJ; Wieler, M	1
Zaleska, B	1
Fahn, S	1
Agid, Y; Anglade, P; Brandel, JP; Duyckaerts, C; Hirsch, EC; Javoy-Agid, F; Lehéricy, S; Scherman, D; Villares, J	1
Agid, Y; Javoy-Agid, F; Ruberg, M; Scherman, D	1
Agid, Y; Faucheux, BA; Hirsch, EC; Marquez, J; Menard, JF; Thibaut, F; Villares, J	1
Albin, RL; Frey, KA; Gilman, S; Kilbourn, MR; Koeppe, RA; Kuhl, DE; Vander Borght, TM	1
Frey, KA; Kilbourn, MR; Wieland, DM	1
Agid, Y; Duyckaerts, C; Faucheux, B; Hauw, JJ; Herrero, MT; Hirsch, EC; Obeso, JA; Villares, J	1
Moy, LY; Sonsalla, PK; Zeevalk, GD	1
Calne, DB; de la Fuente-Fernandez, R; Holden, JE; Lee, CS; Pal, PK; Ruth, TJ; Samii, A; Schulzer, M; Sossi, V; Stoessl, AJ; Wudel, J	1
Stoessl, AJ	1
Davidson, DL; Mawdsley, C; Pullar, IA; Wilson, H; Yates, CM	1
Casabona, J; Jankovic, J	1
Agid, Y; Blin, J; Desnos, C; Javoy-Agid, F; Pierot, L; Raisman, R; Ruberg, M; Scherman, D	1
Dalby, MA	1
McLellan, DL	1
Chase, TN	1
Gordon, N	1
Bergmann, S; Frears, CC; Godwin-Austen, RB	1
Calne, DB; Webster, RA	1

Reviews

8 review(s) available for tetrabenazine and Parkinson Disease

Article	Year
Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders. International journal of molecular sciences, 2021, Nov-18, Volume: 22, Issue:22 Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Brain; Humans; Huntington Disease; Levodopa; Memantine; Microscopy, Electron; Multiple Sclerosis; Neuronal Plasticity; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Parkinson Disease; Synapses; Synaptic Transmission; Tetrabenazine	2021
Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia. Drugs, 2016, Volume: 76, Issue:7 Topics: Antipsychotic Agents; Botulinum Toxins; Dopamine Antagonists; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Parkinson Disease; Quality of Life; Tardive Dyskinesia; Tetrabenazine	2016
How best to address these common movement disorders. The Journal of family practice, 2011, Volume: 60, Issue:12 Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Anticonvulsants; Antiparkinson Agents; Essential Tremor; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Practice Guidelines as Topic; Primidone; Propranolol; Tetrabenazine; Tourette Syndrome; Treatment Outcome	2011
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Experimental neurology, 2003, Volume: 184 Suppl 1 Topics: Animals; Basal Ganglia; Biomarkers; Cocaine; Diagnostic Imaging; Dihydroxyphenylalanine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease; Radiopharmaceuticals; Technology Assessment, Biomedical; Tetrabenazine; Tomography, Emission-Computed, Single-Photon; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2003
The role of radiotracer imaging in Parkinson disease. Neurology, 2005, Jan-25, Volume: 64, Issue:2 Topics: Biomarkers; Biotransformation; Blood-Brain Barrier; Carbon Radioisotopes; Clinical Trials as Topic; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neurons; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Dopamine; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed, Single-Photon	2005
[Progress in the treatment of degenerative diseases of the nervous system. Selected problems]. Neurologia i neurochirurgia polska, 1980, Volume: 14, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Antiparkinson Agents; Humans; Huntington Disease; Lithium; Neostigmine; Parkinson Disease; Penicillamine; Phthalazines; Selegiline; Tetrabenazine; Tiapamil Hydrochloride	1980
Assessing the integrity of the dopamine system in Parkinson's disease: how best to do it? Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:5 Topics: Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Humans; Neural Pathways; Parkinson Disease; Severity of Illness Index; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2001
Serotonergic mechanisms and extrapyramidal function in man. Advances in neurology, 1974, Volume: 5 Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extrapyramidal Tracts; Fenclonine; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Imipramine; Levodopa; Muscular Diseases; Paralysis; Parkinson Disease; Parkinson Disease, Secondary; Probenecid; Reserpine; Serotonin; Spinal Cord Diseases; Tetrabenazine; Time Factors	1974

Trials

2 trial(s) available for tetrabenazine and Parkinson Disease

Article	Year
Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:9 Topics: Drug-Related Side Effects and Adverse Reactions; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Molecular Imaging; Parkinson Disease; Positron-Emission Tomography; Radiometry; Tetrabenazine; Vesicular Monoamine Transport Proteins	2010
Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa. British medical journal, 1971, Nov-27, Volume: 4, Issue:5786 Topics: Age Factors; Aged; Antiemetics; Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Hallucinations; Humans; Hypotension, Orthostatic; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Vomiting	1971

Article

Year

Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:9

Topics: Drug-Related Side Effects and Adverse Reactions; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Molecular Imaging; Parkinson Disease; Positron-Emission Tomography; Radiometry; Tetrabenazine; Vesicular Monoamine Transport Proteins

2010

Effect of age and arteriosclerosis on the response of Parkinsonian patients to levodopa.

British medical journal, 1971, Nov-27, Volume: 4, Issue:5786

Topics: Age Factors; Aged; Antiemetics; Arteriosclerosis; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Hallucinations; Humans; Hypotension, Orthostatic; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Vomiting

1971

Other Studies

73 other study(ies) available for tetrabenazine and Parkinson Disease

Article	Year
Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. Journal of Parkinson's disease, 2022, Volume: 12, Issue:5 Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Levodopa; Mice; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Serotonin; Tetrabenazine	2022
Novel data-driven, equation-free method captures spatio-temporal patterns of neurodegeneration in Parkinson's disease: Application of dynamic mode decomposition to PET. NeuroImage. Clinical, 2020, Volume: 25 Topics: Aged; Dopamine; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Putamen; Tetrabenazine	2020
Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, Volume: 62, Issue:4 Topics: Carbon Radioisotopes; Diffusion Tensor Imaging; Dopamine; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine	2021
[ Annals of nuclear medicine, 2017, Volume: 31, Issue:7 Topics: Acetylcysteine; Animals; Brain; Disease Models, Animal; Fluorine Radioisotopes; Image Processing, Computer-Assisted; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Tetrabenazine	2017
Association between autonomic dysfunction and fatigue in Parkinson disease. Journal of the neurological sciences, 2017, Jun-15, Volume: 377 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Cross-Sectional Studies; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index; Surveys and Questionnaires; Tetrabenazine	2017
Mentally stimulating activities associate with better cognitive performance in Parkinson disease. Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:10 Topics: Aged; Aged, 80 and over; Carbon Isotopes; Cognition Disorders; Cognitive Behavioral Therapy; Female; Humans; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phosphinic Acids; Piperidines; Positron-Emission Tomography; Regression Analysis; Tetrabenazine	2017
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease. Scientific reports, 2017, 07-25, Volume: 7, Issue:1 Topics: alpha-Synuclein; Animals; Carbon Radioisotopes; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Humans; Parkinson Disease; Positron-Emission Tomography; Presynaptic Terminals; Rats; Rats, Transgenic; Substantia Nigra; Synapses; Tetrabenazine; Vesicular Monoamine Transport Proteins	2017
Tetrabenazine and subthalamic stimulation in graft-induced dyskinesias. Neurology, 2017, 09-19, Volume: 89, Issue:12 Topics: Deep Brain Stimulation; Dyskinesias; Electric Stimulation Therapy; Humans; Parkinson Disease; Subthalamic Nucleus; Tetrabenazine	2017
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology, 2018, 06-05, Volume: 90, Issue:23 Topics: Adult; Antiparkinson Agents; Databases, Bibliographic; Deep Brain Stimulation; DiGeorge Syndrome; Female; Humans; International Cooperation; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Sex Distribution; Statistics, Nonparametric; Tetrabenazine; Tomography, Emission-Computed, Single-Photon	2018
In vivo quantification of glial activation in minipigs overexpressing human α-synuclein. Synapse (New York, N.Y.), 2018, Volume: 72, Issue:12 Topics: alpha-Synuclein; Amides; Animals; Brain; Female; HEK293 Cells; Humans; Isoquinolines; Neuroglia; Parkinson Disease; Positron-Emission Tomography; Swine; Swine, Miniature; Tetrabenazine; Vesicular Monoamine Transport Proteins	2018
Quantitative study of Scientific reports, 2018, 10-30, Volume: 8, Issue:1 Topics: Aged; Brain; Case-Control Studies; Female; Fluorine Radioisotopes; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine	2018
Diagnostic Utility of [11C]DTBZ Positron Emission Tomography In Clinically Uncertain Parkinsonism: Experience of a Single Tertiary Center. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2018, Volume: 70, Issue:6 Topics: Adult; Aged; Brain; Carbon Radioisotopes; Female; Humans; Male; Mexico; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tetrabenazine; Tomography, Emission-Computed, Single-Photon	2018
Multimodal dopaminergic and free-water imaging in Parkinson's disease. Parkinsonism & related disorders, 2019, Volume: 62 Topics: Adult; Aged; Aged, 80 and over; Brain; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tremor; Water	2019
Striatal denervation pattern predicts levodopa effects on sequence learning in Parkinson's disease. Journal of motor behavior, 2013, Volume: 45, Issue:5 Topics: Aged; Antiparkinson Agents; Data Interpretation, Statistical; Denervation; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Levodopa; Linear Models; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Serial Learning; Tetrabenazine	2013
The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease. Behavioural brain research, 2013, Nov-15, Volume: 257 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbon Isotopes; Cluster Analysis; Corpus Striatum; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Psychomotor Performance; Tetrabenazine; Time Factors; Time Perception	2013
Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology, 2013, Oct-29, Volume: 81, Issue:18 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Analysis of Variance; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Cross-Sectional Studies; Dioxolanes; Female; Gait Disorders, Neurologic; Humans; Male; Middle Aged; Nerve Degeneration; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins	2013
In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:1 Topics: Adult; Aged; Amines; Biomarkers; Brain; Case-Control Studies; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins	2014
Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients. Nuclear medicine and biology, 2014, Volume: 41, Issue:4 Topics: Aged; Case-Control Studies; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organotechnetium Compounds; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tomography, Emission-Computed, Single-Photon; Tropanes	2014
Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology, 2014, Apr-29, Volume: 82, Issue:17 Topics: Aged; Body Mass Index; Carbon Radioisotopes; Cardiovascular Diseases; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Imaging, Three-Dimensional; Leukoaraiosis; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Radionuclide Imaging; Reference Values; Rhombencephalon; Risk Factors; Severity of Illness Index; Tetrabenazine	2014
Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. JAMA neurology, 2014, Volume: 71, Issue:6 Topics: Adult; Aged; Female; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Tremor	2014
Essential difference between the pharmacological spectrum of (-)-deprenyl and rasagiline. Pharmacological reports : PR, 2014, Volume: 66, Issue:3 Topics: Animals; Indans; Learning Disabilities; Levodopa; Male; Neurons; Parkinson Disease; Rats; Rats, Wistar; Selegiline; Tetrabenazine	2014
Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:9 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Carbon Isotopes; Cross-Sectional Studies; Female; Freezing Reaction, Cataleptic; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Substantia Nigra; Tetrabenazine; Thiazoles; Vesicular Monoamine Transport Proteins	2014
Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Jun-11, Volume: 34, Issue:24 Topics: Aged; Aged, 80 and over; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Female; Homovanillic Acid; Humans; Macaca fascicularis; Male; MPTP Poisoning; Parkinson Disease; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Monoamine Transport Proteins	2014
Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates. Parkinsonism & related disorders, 2014, Volume: 20, Issue:10 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Brain; Cognition Disorders; Female; Guanidines; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins	2014
Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism & related disorders, 2014, Volume: 20, Issue:12 Topics: Aged; Butyrates; Carbon Isotopes; Cognition Disorders; Cross-Sectional Studies; Diabetes Complications; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Parkinson Disease; Piperidines; Positron-Emission Tomography; Severity of Illness Index; Tetrabenazine	2014
Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study. Neurobiology of disease, 2015, Volume: 77 Topics: Adrenergic Agents; Animals; Apomorphine; Brain; Carbon Radioisotopes; Disease Models, Animal; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Functional Laterality; Longitudinal Studies; Magnetic Resonance Imaging; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Rats; Rats, Sprague-Dawley; Statistics, Nonparametric; Tetrabenazine	2015
Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:9 Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Jaw; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tetrabenazine; Tremor	2015
Chronic manganism: A long-term follow-up study with a new dopamine terminal biomarker of 18F-FP-(+)-DTBZ (18F-AV-133) brain PET scan. Journal of the neurological sciences, 2015, Volume: 353, Issue:1-2 Topics: Adrenergic Uptake Inhibitors; Aged; Brain; Case-Control Studies; Dopamine; Female; Fluorine Radioisotopes; Humans; Longitudinal Studies; Male; Manganese Poisoning; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Taiwan; Tetrabenazine; Tomography Scanners, X-Ray Computed	2015
Striatal and Cortical β-Amyloidopathy and Cognition in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, 2016, Volume: 31, Issue:1 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Analysis of Variance; Aniline Compounds; Carbon Isotopes; Cerebral Cortex; Cognition Disorders; Corpus Striatum; Cross-Sectional Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine; Thiazoles	2016
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease. Academic radiology, 2016, Volume: 23, Issue:5 Topics: Aged; Atrophy; Attention; Basal Ganglia; Brain Diseases; Carbon Radioisotopes; Case-Control Studies; Cognition; Cross-Sectional Studies; Diabetes Complications; Dopaminergic Neurons; Executive Function; Female; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Tetrabenazine	2016
CSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report. PloS one, 2016, Volume: 11, Issue:10 Topics: Aged; alpha-Synuclein; Amyloid beta-Peptides; Biomarkers; Brain; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Pilot Projects; Positron-Emission Tomography; tau Proteins; Tetrabenazine; Vesicular Monoamine Transport Proteins	2016
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging. PloS one, 2017, Volume: 12, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biphenyl Compounds; Corpus Striatum; Disease Models, Animal; Fluorine Radioisotopes; Humans; Lignans; Mice; Neurons; Parkinson Disease; Parkinson Disease, Secondary; Positron-Emission Tomography; Tetrabenazine; Vesicular Monoamine Transport Proteins	2017
Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008, Volume: 4, Issue:1 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tetrabenazine	2008
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Sep-24, Volume: 28, Issue:39 Topics: Adult; Analysis of Variance; Brain Mapping; Central Nervous System Stimulants; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substance Withdrawal Syndrome; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins	2008
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias. Neurology, 2009, Apr-07, Volume: 72, Issue:14 Topics: Caudate Nucleus; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Female; Humans; Logistic Models; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Tetrabenazine	2009
Dyskinesia in Parkinson disease: back for the future? Neurology, 2009, Apr-07, Volume: 72, Issue:14 Topics: Antiparkinson Agents; Dopamine Agents; Dyskinesias; Humans; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Synapses; Tetrabenazine	2009
Visualizing vesicular dopamine dynamics in Parkinson's disease. Synapse (New York, N.Y.), 2009, Volume: 63, Issue:8 Topics: Antiparkinson Agents; Brain Mapping; Carbon Radioisotopes; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Nonlinear Dynamics; Parkinson Disease; Positron-Emission Tomography; Tetrabenazine	2009
In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2010, Volume: 51, Issue:2 Topics: Aged; Brain; Case-Control Studies; Caudate Nucleus; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Tetrabenazine; Tissue Distribution; Vesicular Monoamine Transport Proteins	2010
An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2. Nuclear medicine and biology, 2010, Volume: 37, Issue:2 Topics: Animals; Biological Transport; Fluorine Radioisotopes; Halogenation; Male; Mice; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Solid Phase Extraction; Tetrabenazine; Tissue Distribution; Vesicular Monoamine Transport Proteins	2010
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease. Nuclear medicine and biology, 2010, Volume: 37, Issue:4 Topics: Aniline Compounds; Animals; Autoradiography; Disease Models, Animal; Fluorine Radioisotopes; Male; p-Chloroamphetamine; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Radioactive Tracers; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Substrate Specificity; Tetrabenazine; Vesicular Monoamine Transport Proteins	2010
Parkinson's disease and other movement disorders. The American journal of geriatric pharmacotherapy, 2010, Volume: 8, Issue:4 Topics: Adrenergic Uptake Inhibitors; Comorbidity; Humans; Mental Disorders; Parkinson Disease; Patient Care Management; Population Dynamics; Tetrabenazine	2010
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease. Annals of neurology, 2011, Volume: 69, Issue:5 Topics: Adult; Aged; Aging; Carbon Isotopes; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Methylphenidate; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Substantia Nigra; Tetrabenazine; Tritium; Young Adult	2011
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a journal of neurology, 2011, Volume: 134, Issue:Pt 8 Topics: Aged; Aged, 80 and over; Carbon Isotopes; Corpus Striatum; Denervation; Female; Humans; Leukoaraiosis; Male; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Regression Analysis; Substantia Nigra; Tetrabenazine; Vesicular Monoamine Transport Proteins	2011
Tardive syndrome and Parkinson's disease responsive to concomitant tetrabenazine and levodopa therapy. Parkinsonism & related disorders, 2011, Volume: 17, Issue:10 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Depression; Female; Flupenthixol; Humans; Levodopa; Movement Disorders; Parkinson Disease; Tetrabenazine	2011
Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements. Nuclear medicine and biology, 2011, Volume: 38, Issue:8 Topics: Aged; Case-Control Studies; Caudate Nucleus; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Positron-Emission Tomography; Putamen; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins	2011
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function. Neurobiology of aging, 2012, Volume: 33, Issue:4 Topics: alpha-Synuclein; Biomarkers; Carbon Isotopes; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Intracellular Signaling Peptides and Proteins; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Luria-Nebraska Neuropsychological Battery; Male; Methylphenidate; Norway; Oncogene Proteins; Parkinson Disease; Positron-Emission Tomography; Protein Deglycase DJ-1; Protein Serine-Threonine Kinases; Statistics as Topic; Tetrabenazine; United States	2012
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2012, Volume: 32, Issue:8 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Carbon Radioisotopes; Cognition; Corpus Striatum; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Motor Activity; Neocortex; Parkinson Disease; Positron-Emission Tomography; Propionates; Tetrabenazine; Thalamus	2012
Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier. Nuclear medicine and biology, 2012, Volume: 39, Issue:7 Topics: Animals; Binding Sites; Biological Transport; Brain; Drug Carriers; Fluorine Radioisotopes; Haplorhini; Humans; Male; Parkinson Disease; Positron-Emission Tomography; Rats; Tetrabenazine; Vesicular Monoamine Transport Proteins	2012
β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:3 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Aniline Compounds; Carbon Isotopes; Cross-Sectional Studies; Dementia; Female; Gait Disorders, Neurologic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Postural Balance; Psychiatric Status Rating Scales; Sensation Disorders; Severity of Illness Index; Tetrabenazine; Thiazoles	2013
VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET. Synapse (New York, N.Y.), 2003, Volume: 49, Issue:1 Topics: Adolescent; Adult; Carbon Radioisotopes; Corpus Striatum; Cytoplasmic Vesicles; Dopamine; Dopamine Agents; Dystonic Disorders; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Middle Aged; Neuropeptides; Parkinson Disease; Raclopride; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2003
[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. Brain : a journal of neurology, 2003, Volume: 126, Issue:Pt 12 Topics: Aged; Antiparkinson Agents; Dopamine; Fingers; Humans; Image Processing, Computer-Assisted; Levodopa; Middle Aged; Movement; Parkinson Disease; Reaction Time; Synaptic Vesicles; Tetrabenazine; Tomography, Emission-Computed	2003
PET studies and physiopathology of motor fluctuations in Parkinson's disease. Brain : a journal of neurology, 2004, Volume: 127, Issue:Pt 8 Topics: Antiparkinson Agents; Apomorphine; Humans; Levodopa; Movement; Parkinson Disease; Tetrabenazine; Tomography, Emission-Computed	2004
The effect of rare human sequence variants on the function of vesicular monoamine transporter 2. Pharmacogenetics, 2004, Volume: 14, Issue:9 Topics: Adrenergic Uptake Inhibitors; Animals; COS Cells; Dose-Response Relationship, Drug; Genetic Variation; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Mutagenesis, Site-Directed; Mutation; Parkinson Disease; Phenotype; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Tetrabenazine; Transfection; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2004
Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Archives of neurology, 2004, Volume: 61, Issue:12 Topics: Aged; Brain; Disease Progression; Dopamine; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Regression Analysis; Tetrabenazine	2004
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 12 Topics: Adult; Age Factors; Aged; Brain; Carbon Radioisotopes; Carboxy-Lyases; Case-Control Studies; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Humans; Image Processing, Computer-Assisted; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Methylphenidate; Middle Aged; Mutation; Parkinson Disease; Phenotype; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Receptors, Dopamine D2; Regression Analysis; Tetrabenazine	2005
Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2006, Volume: 26, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Aging; Algorithms; Biogenic Monoamines; Female; Humans; Male; Middle Aged; Neostriatum; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins	2006
Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease. Annals of neurology, 2008, Volume: 63, Issue:3 Topics: Adult; Aged; Corpus Striatum; Cross-Sectional Studies; Early Diagnosis; Female; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Protein Binding; Tetrabenazine	2008
Long-term treatment of tardive dyskinesia with presynaptically acting dopamine-depleting agents. Advances in neurology, 1983, Volume: 37 Topics: Adult; Aged; alpha-Methyltyrosine; Carbidopa; Dopamine; Dopamine Antagonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reserpine; Synapses; Tetrabenazine	1983
Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography. Brain research, 1994, Oct-03, Volume: 659, Issue:1-2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Binding Sites; Biogenic Monoamines; Corpus Striatum; Female; Humans; Male; Middle Aged; Parkinson Disease; Reference Values; Tetrabenazine; Tritium	1994
Dopamine denervation, age of onset, and Parkinson's disease. Neurology, 1995, Volume: 45, Issue:2 Topics: Age of Onset; Aged; Caudate Nucleus; Denervation; Dopamine; Humans; Middle Aged; Parkinson Disease; Tetrabenazine; Tritium	1995
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine. Brain research, 1995, Sep-18, Volume: 692, Issue:1-2 Topics: Acetylcholinesterase; Aged; Aged, 80 and over; Biogenic Monoamines; Female; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Mesencephalon; Middle Aged; Parkinson Disease; Receptors, Dopamine; Receptors, Neurotransmitter; Receptors, Serotonin; Substantia Nigra; Tetrabenazine; Tyrosine 3-Monooxygenase	1995
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of neurology, 1996, Volume: 40, Issue:6 Topics: Adult; Aged; Aging; Animals; Biological Transport; Biomarkers; Blood-Brain Barrier; Cerebral Cortex; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Rats; Tetrabenazine; Tomography, Emission-Computed; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	1996
Imaging of monoaminergic and cholinergic vesicular transporters in the brain. Advances in pharmacology (San Diego, Calif.), 1998, Volume: 42 Topics: Acetylcholine; Alzheimer Disease; Brain; Carbon Radioisotopes; Carrier Proteins; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Neuromuscular Depolarizing Agents; Neurons; Neuropeptides; Neurotransmitter Agents; Parkinson Disease; Piperidines; Tetrabenazine; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tritium; Vesicular Acetylcholine Transport Proteins; Vesicular Biogenic Amine Transport Proteins; Vesicular Transport Proteins	1998
[125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys. Experimental neurology, 1998, Volume: 154, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Animals; Basal Ganglia; Brain Diseases; Dopamine Agents; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immunohistochemistry; Iodine Radioisotopes; Macaca fascicularis; Male; Parkinson Disease; Supranuclear Palsy, Progressive; Tetrabenazine	1998
Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. Journal of neurochemistry, 2000, Volume: 74, Issue:4 Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Biological Transport; Carbon Radioisotopes; Cells, Cultured; Corpus Striatum; Dopamine; Energy Metabolism; Free Radicals; gamma-Aminobutyric Acid; Lactic Acid; Male; Malonates; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Nerve Degeneration; Neurons; Neuropeptides; Parkinson Disease; Presynaptic Terminals; Synaptic Vesicles; Tetrabenazine; Tritium; Vesicular Biogenic Amine Transport Proteins	2000
In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Annals of neurology, 2000, Volume: 47, Issue:4 Topics: Aged; Carbon Radioisotopes; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Down-Regulation; Fluorine Radioisotopes; Homovanillic Acid; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Presynaptic Terminals; Tetrabenazine; Tomography, Emission-Computed	2000
CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12 Topics: Aged; Athetosis; Carbidopa; Chorea; Dihydroxyphenylalanine; Dopamine; Dystonia Musculorum Deformans; Hepatolenticular Degeneration; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Serotonin; Tetrabenazine; Torticollis	1977
Coexistent tardive dyskinesia and parkinsonism. Clinical neuropharmacology, 1987, Volume: 10, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reserpine; Tetrabenazine	1987
D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy. Journal of the neurological sciences, 1988, Volume: 86, Issue:2-3 Topics: Adenylyl Cyclases; Adult; Aged; Benzazepines; Caudate Nucleus; Dopamine Antagonists; Humans; Middle Aged; Parkinson Disease; Putamen; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reference Values; Spiperone; Supranuclear Palsy, Progressive; Tetrabenazine	1988
Effect of tetrabenazine on extrapyramidal movement disorders. British medical journal, 1969, May-17, Volume: 2, Issue:5654 Topics: Chorea; Extrapyramidal Tracts; Female; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Tetrabenazine	1969
The suppression of involuntary movements with tetrabenazine. Scottish medical journal, 1972, Volume: 17, Issue:11 Topics: Adolescent; Adult; Aged; Ataxia; Athetosis; Depression; Diencephalon; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Tetrabenazine; Time Factors; Tremor	1972
Drugs and motor functions. Developmental medicine and child neurology, 1971, Volume: 13, Issue:3 Topics: Athetosis; Catecholamines; Cholinesterase Inhibitors; Chorea; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Histamine H1 Antagonists; Humans; Motor Activity; Movement Disorders; Parkinson Disease; Phenothiazines; Reserpine; Tetrabenazine	1971
Tremor induced by tetrabenazine. British journal of pharmacology, 1969, Volume: 37, Issue:2 Topics: Amobarbital; Animals; Body Temperature; Cats; Disease Models, Animal; Hot Temperature; Parkinson Disease; Scopolamine; Shivering; Sleep; Tetrabenazine; Tremor	1969